COMP <GO>
MMSI vs HAE // 10Y YIELD & FRED MACRO BETA
Merit Medical Systems Inc. (NASDAQ) VS. Haemonetics Corporation (NYSE) • 15-METRIC TALLY: MMSI 6
— HAE 6
▲ 10Y YIELD & FRED MACRO BETA LEADER: HAE
LAST: $86.24 (-7.66%) • MKT CAP: $5.17B
macro-sensitivity
0.94
LAST: $119.65 (-0.12%) • MKT CAP: $5.44B
macro-sensitivity
1.00
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMSI VS. HAE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMSI | HAE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.70% | 59.00% | -10.30 | HAE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | 8.40% | -0.60 | HAE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.1x | 32.5x | -9.40 | MMSI | /valuation <GO> |
| Free Cash Flow Yield | 3.87% | 4.78% | -0.91 | HAE | /fcf-yield <GO> |
| Operating Margin | 12.20% | 11.70% | +0.50 | MMSI | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 0.00% | +8.50 | MMSI | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | -2.00% | +13.80 | MMSI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 3.89 | +0.73 | MMSI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | MMSI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.5 | 63.0 | -19.50 | HAE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.94 | 1.00 | -0.06 | HAE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 40.4x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.17B | $5.44B | -$276.6M | HAE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMSI REV | HAE REV | MMSI GROSS % | HAE GROSS % | MMSI FCF | HAE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $1.33B | 48.7% | 59.0% | $215.7M | $260.4M |
| FY 2024 | $1.36B | $1.36B | 47.4% | 55.0% | $185.7M | $142.4M |
| FY 2023 | $1.26B | $1.31B | — | — | $88.6M | $122.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMSI // BETA 0.94
HAE // BETA 1.00